Sign In
Buy DXR
$10.50
-0.345 (-3.18%)
At Close: Jul 31, 2026
Daxor Corporation Expands Blood Volume Analysis Technology to Major New Jersey Hospitals
08:00am, Thursday, 27'th Feb 2025
Leading Academic Health System Adopts Daxor's Innovative Blood Volume Measurement Capabilities at Two Key Facilities Oak Ridge, TN, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), t
Daxor Corporation Announces New Data on Blood Volume Analysis from Duke and Yale Universities Presented at THT 2025
08:00am, Wednesday, 19'th Feb 2025
Two Groundbreaking Studies on Fluid Management: Pulmonary Artery Pressure Monitoring Falls Short, New Diuretic Insights Emerge Oak Ridge, TN, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasda
TruLite Health Bolsters Health Equity Expertise with Expanded Leadership Team
10:50am, Tuesday, 18'th Feb 2025
TEMPE, Ariz.--(BUSINESS WIRE)--TruLite Health, developer of the only health equity solution to remediate clinical bias, has expanded the leadership team as the company strengthens artificial intellige
Daxor to Exhibit at World's Largest Critical Care Conference
08:00am, Tuesday, 18'th Feb 2025
Daxor's Blood Volume Analysis (BVA) Technology Takes Center Stage at SCCM 2025 Oak Ridge, TN, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measu
Daxor's Blood Volume Analysis Uncovers Hidden Heart Failure Subtype in Nearly 1 in 5 Patients, Enabling Targeted Treatment
08:00am, Friday, 14'th Feb 2025
Case Reports in the Journal of the American College of Cardiology Underscore the Critical Role of Blood Volume Analysis in Optimizing Heart Failure Treatment Oak Ridge, TN, Feb. 14, 2025 (GLOBE NEWSW
New Multicenter Study Highlights Utility of Daxor's Blood Volume Analysis in Heart Failure Care
08:00am, Thursday, 13'th Feb 2025
Research Published in the Prestigious Journal of Cardiac Failure From Three Institutions Oak Ridge, TN, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood vo
Daxor Expands Its BVA-100™ Blood Volume Diagnostic to Two New Hospital Systems Adding to Sales Momentum
08:00am, Wednesday, 18'th Dec 2024
Healthcare Providers Embrace Blood Volume Analysis (BVA) in Nephrology and Heart Failure Outpatient Care Oak Ridge, TN, Dec. 18, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global le
DAXOR'S INNOVATIVE BVA-100™ BLOOD VOLUME DIAGNOSTIC FEATURED AT MEDAXIOM CV TRANSFORUM FALL '24
08:00am, Wednesday, 09'th Oct 2024
Elite Cardiovascular Leaders Unite: Driving Innovation Through Shared Excellence Oak Ridge, TN, Oct. 09, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ: DXR), the global leader in blood volume mea
Daxor Corporation to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit
08:00am, Tuesday, 08'th Oct 2024
Oak Ridge, TN, Oct. 08, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, announces today that CEO and President Michael Feldschuh wil
Daxor Corporation Streamlines Regulatory Strategy for Groundbreaking Diagnostic Device
05:00pm, Friday, 27'th Sep 2024
Company to Focus on 510(k) Approval Path, Accelerating Time-to-Market Oak Ridge, TN, Sept. 27, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ: DXR), the global leader in blood volume measurement t
Daxor Corporation to Exhibit at the Heart Failure Society of America Annual Scientific Meeting 2024
08:00am, Thursday, 19'th Sep 2024
Oak Ridge, TN, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ: DXR), the global leader in blood volume measurement technology, today announces its participation in the Annual Scientific
Leading Central Florida Hospital Implements Daxor's BVA-100™ Blood Volume Diagnostic for Heart Failure Patient Care
08:30am, Wednesday, 04'th Sep 2024
1,000 Bed Comprehensive Medical Center Launches ezBVA Lab Program Oak Ridge, TN, Sept. 04, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement techn
Daxor Corporation CEO and President Michael Feldschuh Delivers Corporate Update in Shareholder Letter
04:05pm, Tuesday, 03'rd Sep 2024
Oak Ridge, TN, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today provides a mid-year corporate and financial update in
Daxor Corporation to Present at the H.C. Wainwright 26th Annual Global Investment Conference
12:15pm, Tuesday, 03'rd Sep 2024
Oak Ridge, TN, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, announces today that CEO and President Michael Feldschuh wi
Daxor Corporation Announces Launch of BVA Program at Mid-South Largest Integrated Network
08:00am, Thursday, 29'th Aug 2024
Community Hospital Purchases BVA Analyzer With Focus on Improving Outpatient Heart Failure Care Oak Ridge, TN, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in b
